Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for prevention of excessive aortic root dilatation in pediatric Marfan syndrome
2009-016139-36Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of losartan in Marfan syndrome (MFS), sponsored by Medical University of Vienna. Primary endpoints: Aortic root diameter progression and Vascular wall stiffness. Started Oct 2009; status: completed.
02
Drugs
losartan
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on 2009-016139-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016139-36.